Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

Clinical trial NCT05245500 · RECRUITING

Trial details

NCT number: NCT05245500
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Mesothelioma Non Small Cell Lung Cancer Malignant Peripheral Nerve Sheath Tumors Solid Tumor Pancreatic Adenocarcinoma Advanced Solid Tumor

Start date: 2022-06-09
Primary completion: 2027-12-10
Enrollment: 336

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.